Pointing the Finger: When Defective IP Due Diligence Wrecks the Deal

November 30, 2018 12:00pm

Drew Holmes, Ph.D.
Senior Patent Attorney
Novartis Pharmaceuticals Corp. (East Hanover, NJ)

Jane M. Love, Ph.D.
Gibson, Dunn & Crutcher LLP (New York, NY)

When it comes to the next huge deal, get your name in the headlines for leading a successful transaction, not for the “oops-I-didn’t-realize-I-can’t-usethe-trademark.” This panel will discuss real-life situations of IP due diligence errors or omissions resulting in deal failure, litigation, and/or other substantial loss of money. Our speakers will lead an interactive discussion on dissecting the deal, decisions made at critical junctures, as well as what could have been done differently to possibly have resulted result in an alternate outcome.